J. Nandi et al., EFFECTS OF A PHORBOL ESTER AND ISOQUINOLINE SULFONAMIDES ON RABBIT PARIETAL-CELL FUNCTION, The Journal of pharmacology and experimental therapeutics, 279(1), 1996, pp. 97-105
The role of protein kinase C (PKC) on gastric H+ secretion, as measure
d by aminopyrine (AP) uptake and other intracellular signal transducti
on products, was investigated in isolated rabbit parietal cells using
the PKC activator 12-O-tetradecanoyl phorbol 13-acetate (TPA) and seve
ral PKC inhibitors, including isoquinoline sulfonamides (H-7, H-8, H-8
9 and HA-1004) and calphostin-C. TPA dose-dependently inhibited histam
ine (10(-4) M)- and carbachol (10(-4) M)-stimulated AP uptake without
affecting the response to dibutyryl cyclic AMP (10(-3) M). H-7 and cal
phostin-C dose-dependently augmented secretagogue-stimulated AP uptake
, whereas H-8 and H-89 inhibited the response to secretagogues, and HA
-1004 had no effect. H-7 and calphostin-C-induced augmentation of AP u
ptake was blocked by a calcium (Ca++) antagonist, lanthanum chloride,
which suggests that the enhanced AP response was regulated by extracel
lular Ca++. Moreover, H-7 treatment partially reversed the TPA (10(-7)
M)-induced inhibition of secretagogue-stimulated AP uptake. TPA reduc
ed histamine- and carbachol-stimulated cAMP and inositol 1,4,5-triphos
phate production by 50% and 96%, respectively, with a concomitant redu
ction of adenylate cyclase and intracellular free Ca++ by 44% and 78%.
TPA increased the distribution of membrane-associated PKC by 20% and
decreased histamine-stimulated PKA by 30%. In contrast, H-7 inhibited
both PKC and protein tyrosine kinase activity in vitro but had no effe
ct on these parameters in vivo. The results indicate that TPA-induced
inhibition of secretagogue-stimulated AP uptake in PC is presumably me
diated by activation of PKC.